April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Inhibitory Role of ICOS on Corneal Lymphangiogenesis and Involvement of Foxp3+CD4+T Regulatory Cells in Secondary Lymphoid Organs
Author Affiliations & Notes
  • Misao Terada
    Division of Laboratory Animal Science,
    Nippon Medical School, Bunkyo-ku, Japan
  • Hiroko Taniguchi
    Nippon Medical School, Bunkyo-ku, Japan
  • Kazuichi Maruyama
    Ophthalmology, Kyoto Prefectural Univ of Med, Kamigyo-ku, Japan
  • Ryo Abe
    Immunology, Research Institute for Biological Science, Tokyo University of Science, Noda, Japan
  • Junko Hori
    Nippon Medical School, Bunkyo-ku, Japan
  • Footnotes
    Commercial Relationships  Misao Terada, None; Hiroko Taniguchi, None; Kazuichi Maruyama, None; Ryo Abe, None; Junko Hori, None
  • Footnotes
    Support  Grant-in-Aid for Scientific Research(C) from the Japan Society for the Promotion of Science
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4364. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Misao Terada, Hiroko Taniguchi, Kazuichi Maruyama, Ryo Abe, Junko Hori; Inhibitory Role of ICOS on Corneal Lymphangiogenesis and Involvement of Foxp3+CD4+T Regulatory Cells in Secondary Lymphoid Organs. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4364.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Interaction between the inducible costimulatory molecule (ICOS) and its ligand, B7-related protein (B7RP-1), has been reported to have an impact on differentiation and functions of various T regulatory cells. We have previously shown that blockade of ICOS/B7RP-1 led to an accelerated corneal allograft rejection. The purpose of the present study is to further investigate the role of ICOS on inflammatory lymphoangiogeneisis in the cornea and its mechanisms.

Methods: : The mouse model of suture-induced inflammatory corneal neovascularization was used. After placement of sutures into the corneal stroma of ICOS-/- (BALB/c background) and W/T mice, hem- and lymphangiogenesis were evaluated using double immunohistochemistry of whole-mount corneas with CD31/PECAM1 as a panendothelial marker and LYVE-1 as a lymphatic endothelial marker. The areas of blood and lymphatic vessels in the inflamed cornea were analyzed and quantified using NIH image J software to compare the outgrowth of vessels between ICOS-/- and W/T mice. Spleen and cervical lymph node cells in these mice were also assessed for Foxp3+CD4+ cells by flow cytometry.

Results: : The outgrowth of blood and lymphatic vessels in ICOS-/- mice were statistical indistinguishable from those in W/T mice at 7 days. However, ICOS-/- mice developed significantly greater lymphatic vessels than W/T mice at 14 days (p<0.05). Whereas there was no difference in the proportion of Foxp3+cells in CD4+T cells of lymph nodes between ICOS-/- and W/T mice at 7 days, ICOS-/- mice showed a significantly lower proportion of these cells than W/T mice at 14 days. In splenic CD4+cells, the proportion of Foxp3+ cells in ICOS-/- mice was significantly lower than that in W/T mice at 7 and 14 days (p<0.01, p<0.05, respectively).

Conclusions: : ICOS plays an inhibitory role on corneal inflammatory lymphangiogenesis. It is indicated that ICOS-mediated Foxp3+CD4+T regulatory cells developed in the secondary lymphoid organs may contribute to inhibit corneal lymphangiogenesis.

Keywords: immunomodulation/immunoregulation • inflammation • neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.